annb0t
Top 20
AngioDynamics, Inc. ANGO recently announced the initiation of a clinical study, AMBITION BTK, comparing the Auryon Atherectomy System Used in Combination with Standard Balloon Angioplasty with Standard Balloon Angioplasty Alone for Treating Infrapopliteal Lesions in patients with critical limb ischemia below-the-knee (BTK).
The trial evaluates the effectiveness of the innovative Auryon atherectomy system in complex BTK cases.
Likely Trend of ANGO Stock Following the News
Following...
>>> Read more: ANGO Stock Looks Promising on New Ischemia Study for Auryon System
The trial evaluates the effectiveness of the innovative Auryon atherectomy system in complex BTK cases.
Likely Trend of ANGO Stock Following the News
Following...
>>> Read more: ANGO Stock Looks Promising on New Ischemia Study for Auryon System
